Loading...
Loading...
Celgene Corp
CELG shares are trading higher by $2 at $107.11 in Thursday's session. The catalyst for the rally is unconfirmed market chatter of Merck
MRK making offer an offer for the biotech company.
The issue, which has been higher in three of four previous sessions has rallied from May 19 close ($99.94) to as high as $107.40 in toiday's session and is not far off that level.
That marks the highest level for the issue since it peaked on April 29 at $108.34.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in